ClinicalTrials.Veeva

Menu

Lactation Fortification Study

Abbott logo

Abbott

Status and phase

Completed
Phase 3

Conditions

Lactation

Treatments

Dietary Supplement: Similac Prenatal Vitamin soft-gel capsule
Dietary Supplement: Placebo (soybean oil and dl-alpha-tocopheryl acetate)

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

To investigate the impact of nutrient supplementation during lactation on levels in breast milk.

Enrollment

89 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Subjects will be eligible for the study if they meet all of the following inclusion criteria:

  1. Mother with singleton birth, 37-42 weeks gestation and ≥ 2490g
  2. Pre-pregnancy BMI </= 30
  3. Mother is ≥ 18 years of age
  4. Mother is 4-6 weeks postpartum and has been successfully continuously lactating
  5. Mother agrees to abstain from the use of any Docosahexaenoic acid (DHA), lutein and/or vitamin E containing supplements for at least 10 days prior to providing a baseline breast milk sample
  6. Mother agrees to abstain from the use of non-study supplements throughout the study
  7. Mother plans to continue breastfeeding for at least 6 weeks from the start of the study
  8. No significant ongoing medical problems in the infant as determined from infant's medical history as related by the parent(s) to the enrolling center personnel

Exclusion criteria

Subjects will be excluded from the study if they meet any of the following criteria:

  1. Subject had adverse maternal and/or fetal medical history
  2. Subject is participating in a non-Abbott approved concomitant trial
  3. Mother is taking cholesterol medication and/or medication affecting lipid absorption and/or transport

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

89 participants in 3 patient groups, including a placebo group

Control Supplement
Placebo Comparator group
Description:
soft-gel placebo capsules, 2 capsules from the placebo bottle per day
Treatment:
Dietary Supplement: Placebo (soybean oil and dl-alpha-tocopheryl acetate)
Experimental Supplement A
Experimental group
Description:
soft-gel capsules; 1 capsule from the experimental bottle and 1 capsule from the placebo bottle per day
Treatment:
Dietary Supplement: Placebo (soybean oil and dl-alpha-tocopheryl acetate)
Dietary Supplement: Similac Prenatal Vitamin soft-gel capsule
Experimental Supplement B
Experimental group
Description:
soft-gel capsules; 2 capsules from the experimental bottle per day
Treatment:
Dietary Supplement: Similac Prenatal Vitamin soft-gel capsule

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems